As the DC vaccine is injected intratumorally, this establishes a gradient of CCL21 that promotes infiltration of those endogenous cells into the tumor, which has been shown to increase synergistic anti-tumor effects between adoptive and endogenous cells [54]. Here, CCL21 is linked to neoplasm.